Showing results (431-440 of 2,229) with videos related to
Sort By:
Pageof 223
Cancer Biotherapy & Radiopharmaceuticals|March 17, 2015
Expression and significance of CDC25B, PED/PEA-15 in esophageal carcinomaMing Wang, Xiao-Yang Zhu, Liang Wang, et al.Cancer Biotherapy & Radiopharmaceuticals|September 20, 2012
Preparation and characterization of nano-liposome-mediated FL gene in the Lovo cellsNian-Feng Sun, Ai-Ling Tian, Yong-Xin Hua, et al.Cancer Biotherapy & Radiopharmaceuticals|August 4, 2012
Preclinical evaluation of VB6-845: an anti-EpCAM immunotoxin with reduced immunogenic potentialJoycelyn Entwistle, Jennifer G Brown, Shilpa Chooniedass, et al.Cancer Biotherapy & Radiopharmaceuticals|September 13, 2012
The practicality of nanoceria-PAN-based (68)Ge/(68)Ga generator toward preparation of (68)Ga-labeled cyclic RGD dimer as a potential PET radiotracer for tumor imagingSudipta Chakraborty, Rubel Chakravarty, Haladhar D Sarma, et al.Cancer Biotherapy & Radiopharmaceuticals|September 6, 2012
Early growth response protein-1 promoter-mediated synergistic antitumor effect of hTERTC27 gene therapy and 5-Flurorouracil on nasopharyngeal carcinomaGuimiao Lin, Marie Chia-Mi Lin, Suxia Lin, et al.Cancer Biotherapy & Radiopharmaceuticals|August 9, 2020
The Regulatory Mechanisms of Dynamin-Related Protein 1 in Tumor Development and TherapyPeiyu Han, Xinlu Ren, Xiuxia Qu, et al.Cancer Biotherapy & Radiopharmaceuticals|August 22, 2020
Sevoflurane Represses Proliferation and Migration of Glioma Cells by Regulating the ANRIL/let-7b-5p AxisYufeng Gao, Hui Ma, Dongnan HouCancer Biotherapy & Radiopharmaceuticals|June 30, 2020
LncRNA ELF3-AS1 Promotes Non-Small Cell Lung Cancer Cell Invasion and Migration by Downregulating miR-212Zhe Zhang, Li Nong, Meng-Lei Chen, et al.Cancer Biotherapy & Radiopharmaceuticals|June 19, 2012
Clinical implications of CD44+/CD24- tumor cell ratio in breast cancerCaigang Liu, Yang Luo, Xing Liu, et al.Cancer Biotherapy & Radiopharmaceuticals|July 5, 2012
Ouabain targets the unfolded protein response for selective killing of HepG2 cells during glucose deprivationTulay Ozdemir, Rukiye Nar, Veli Kilinc, et al.Pageof 223